Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria
Clinical trial NCT04402489 · COMPLETED
Trial details
- NCT number
- NCT04402489
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-12-14
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.